Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI
Juan Zhang,Yinqiao Li,Jinju Xia,Xingpeng Pan,Lun Lu,Jiazhao Fu,Ningyang Jia
DOI: https://doi.org/10.2147/jhc.s459686
2024-05-25
Journal of Hepatocellular Carcinoma
Abstract:Juan Zhang, 1, &ast Yinqiao Li, 1, 2, &ast Jinju Xia, 1 Xingpeng Pan, 1 Lun Lu, 1 Jiazhao Fu, 3 Ningyang Jia 1 1 Department of Radiology, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital of Naval Medical University, Shanghai, China; 2 School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China; 3 Department of Organ Transplantation, Changhai Hospital, First Affiliated Hospital of Naval Medical University, Shanghai, China &astThese authors contributed equally to this work Correspondence: Jiazhao Fu; Ningyang Jia, Email ; Objective: This study aims to investigate the predictive value of Gadobenate dimeglumine (Gd-BOPTA) enhanced MRI features on microvascular invasion (MVI) and recurrence in patients with Liver Imaging Reporting and Data System (LI-RADS) category 5 hepatocellular carcinoma (HCC). Methods: A total of 132 patients with LI-RADS category 5 HCC who underwent curative resection and Gd-BOPTA enhanced MRI at our hospital between January 2016 and December 2018 were retrospectively analyzed. Qualitative evaluation based on LI-RADS v2018 imaging features was performed. Logistic regression analyses were conducted to assess the predictive significance of these features for MVI, and the Cox proportional hazards model was used to identify postoperative risk factors of recurrence. The recurrence-free survival (RFS) was analyzed by using the Kaplan–Meier curve and Log rank test. Results: Multivariate logistic regression analysis identified that corona enhancement (odds ratio [OR] = 3.217; p < 0.001), internal arteries (OR = 4.147; p = 0.004), and peritumoral hypointensity on hepatobiliary phase (HBP) (OR = 5.165; p < 0.001) were significantly associated with MVI. Among the 132 patients with LR-5 HCC, 62 patients experienced postoperative recurrence. Multivariate Cox regression analysis showed that mosaic architecture (hazard ratio [HR] = 1.982; p = 0.014), corona enhancement (HR = 1.783; p = 0.039), and peritumoral hypointensity on HBP (HR = 2.130; p = 0.009) were risk factors for poor RFS. Conclusion: MRI features based on Gd-BOPTA can be noninvasively and effectively predict MVI and recurrence of LR-5 HCC patients. Keywords: hepatocellular carcinoma, magnetic resonance imaging, microvascular invasion, prognosis Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer, ranking third among all cancer-related death globally. 1 Hepatic resection remains the most effective treatment option among the recommended treatment options for HCC patients. However, the 5-year postoperative recurrence rate is as high as 50%–70%, 2 and the 5-year disease-free survival rate remains low. 3 Microvascular invasion (MVI), typically characterized by the microscopic detection of cancer cell nests within endothelium-lined blood vessels, serves as a significant predictor of post-surgical recurrence and overall poor survival in HCC patients. 4–7 Prior research has suggested that surgical resection and radiofrequency ablation should be accompanied by wider resection margin, and liver transplantation should also be considered as a potential treatment option for HCC patients with MVI. 8 Therefore, the early and accurate prediction of MVI in HCC patients may optimize patient management and improve prognosis. Nevertheless, MVI can only be confirmed through histopathologically. Attempts to detect MVI in hepatocellular carcinoma using imaging methods have been ongoing. A number of studies have reported various MRI features that may predict MVI, including non-smooth tumor margin, 7,9–11 rim arterial enhancement, 12,13 arterial peritumoral enhancement, 7,14 and peritumoral hypointensity on hepatobiliary phase (HBP). 7,9,11,13 However, these MRI findings remain controversial, and several models constructed from MRI features lack reliability and reproducibility. Gadobenate dimeglumine (Gd-BOPTA) is distributed in the extracellular space and specifically taken up by hepatocytes, 13 thus it is applied as a hepatobiliary-specific contrast agent for clinical examination. The Liver Imaging Reporting and Data System (LIRDS) is a liver imaging examination specification and diagnostic classification system that provides a detailed introduction and standardized requirements for imaging examination techniques, sign description terminology, diagnostic reporting, and data collection for high-risk populations with HCC. 15 Although it has been previously reported in th -Abstract Truncated-
oncology